|Quantitative optical spectroscopy for tissue diagnosis|
R Richards-Kortum, E Sevick-Muraca
Annual review of physical chemistry 47 (1), 555-606, 1996
|Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology|
U Prabhakar, H Maeda, RK Jain, EM Sevick-Muraca, W Zamboni, ...
Cancer research 73 (8), 2412-2417, 2013
|Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions|
JR Less, TC Skalak, EM Sevick, RK Jain
Cancer research 51 (1), 265-273, 1991
|Quantitation of time-and frequency-resolved optical spectra for the determination of tissue oxygenation|
EM Sevick, B Chance, J Leigh, S Nioka, M Maris
Analytical biochemistry 195 (2), 330-351, 1991
|Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents1|
DJ Hawrysz, EM Sevick-Muraca
Neoplasia 2 (5), 388-417, 2000
|Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents|
EM Sevick-Muraca, JP Houston, M Gurfinkel
Current opinion in chemical biology 6 (5), 642-650, 2002
|Near-infrared fluorescence imaging in humans with indocyanine green: a review and update|
MV Marshall, JC Rasmussen, IC Tan, MB Aldrich, KE Adams, X Wang, ...
Open surgical oncology journal (Online) 2 (2), 12, 2010
|Fluorescence imaging system and method|
EM Sevick-Muraca, DY Paithankar
US Patent 5,865,754, 1999
|Imaging of Lymph Flow in Breast Cancer Patients after Microdose Administration of a Near-Infrared Fluorophore: Feasibility Study1|
EM Sevick-Muraca, R Sharma, JC Rasmussen, MV Marshall, JA Wendt, ...
Radiology 246 (3), 734-741, 2008
|Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts|
S Ke, X Wen, M Gurfinkel, C Charnsangavej, S Wallace, ...
Cancer research 63 (22), 7870-7875, 2003
|Translation of near-infrared fluorescence imaging technologies: emerging clinical applications|
Annual review of medicine 63, 217-231, 2012
|Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer|
KE Adams, S Ke, S Kwon, F Liang, Z Fan, Y Lu, K Hirshi, ME Mawad, ...
Journal of biomedical optics 12 (2), 024017, 2007
|Imaging of spontaneous canine mammary tumors using fluorescent contrast agents|
JS Reynolds, TL Troy, RH Mayer, AB Thompson, DJ Waters, KK Cornell, ...
Photochemistry and Photobiology 70 (1), 87-94, 1999
|Imaging of fluorescent yield and lifetime from multiply scattered light reemitted from random media|
DY Paithankar, AU Chen, BW Pogue, MS Patterson, EM Sevick-Muraca
Applied Optics 36 (10), 2260-2272, 1997
|Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats|
MV Marshall, D Draney, EM Sevick-Muraca, DM Olive
Molecular Imaging and Biology 12 (6), 583-594, 2010
|Optical properties of normal and diseased breast tissues: prognosis for optical mammography|
TL Troy, DL Page, EM Sevick-Muraca
Journal of biomedical optics 1 (3), 342-355, 1996
|Lymphatic imaging in humans with near-infrared fluorescence|
JC Rasmussen, IC Tan, MV Marshall, CE Fife, EM Sevick-Muraca
Current opinion in biotechnology 20 (1), 74-82, 2009
|Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer|
L Sampath, S Kwon, S Ke, W Wang, R Schiff, ME Mawad, ...
Journal of Nuclear Medicine 48 (9), 1501-1510, 2007
|Pharmacokinetics of ICG and HPPH‐car for the Detection of Normal and Tumor Tissue Using Fluorescence, Near‐infrared Reflectance Imaging: A Case Study¶|
M Gurfinkel, AB Thompson, W Ralston, TL Troy, AL Moore, TA Moore, ...
Photochemistry and photobiology 72 (1), 94-102, 2000
|Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure|
EM Sevick, RK Jain
Cancer research 49 (13), 3506-3512, 1989